מדינה: אירלנד
שפה: אנגלית
מקור: HPRA (Health Products Regulatory Authority)
Tiotropium
IMED Healthcare Ltd.
R03BB04
Tiotropium
2.5 microgram(s)
Inhalation solution
tiotropium bromide
2011-09-30
PACKAGE LEAFLET: INFORMATION FOR THE USER SPIRIVA ® RESPIMAT ® 2.5 MICROGRAM, INHALATION SOLUTION tiotropium READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Spiriva Respimat is and what it is used for 2. What you need to know before you take Spiriva Respimat 3. How to take Spiriva Respimat 4. Possible side effects 5. How to store Spiriva Respimat 6. Contents of the pack and other information 1. WHAT SPIRIVA RESPIMAT IS AND WHAT IT IS USED FOR Spiriva Respimat helps people who have chronic obstructive pulmonary disease (COPD) or asthma to breathe more easily. COPD is a long-term lung disease that causes shortness of breath and coughing. The term COPD is associated with the conditions chronic bronchitis and emphysema. Asthma is a long-term disease characterised by airway inflammation and narrowing of the airways. As COPD and asthma are long-term diseases you should take Spiriva Respimat every day and not only when you have breathing problems or other symptoms. When used to treat asthma you should take Spiriva Respimat in addition to so-called inhaled corticosteroids and long-acting β 2 agonists. Spiriva Respimat is a long-acting bronchodilator that helps to open your airways and makes it easier to get air in and out of the lungs. Regular use of Spiriva Respimat can also help you when you have on-going shortness of breath related to your disease, and will help to minimise the effects of the disease on your everyday life. Daily use of Spiriva Respimat will also help to prevent any sudden, short-t קרא את המסמך השלם
Health Products Regulatory Authority 22 December 2021 CRN00CNCX Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Spiriva Respimat 2.5 microgram, inhalation solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION The delivered dose is 2.5 microgram tiotropium per puff (2 puffs comprise one medicinal dose) and is equivalent to 3.124 microgram tiotropium bromide monohydrate. The delivered dose is the dose which is available for the patient after passing the mouthpiece. Excipient with known effect: This medicine contains 0.0011 mg benzalkonium chloride in each actuation. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Inhalation solution _Product imported from France_ Clear, colourless, inhalation solution 4 CLINICAL PARTICULARS As per PA0775/002/002 5 PHARMACOLOGICAL PROPERTIES As per PA0775/002/002 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Benzalkonium chloride Disodium edetate Purified water Hydrochloric acid 3.6 % (for pH adjustment) 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf life expiry date of this product shall be the date shown on the containers and outer package of the product as marketed in the country of origin. In-use shelf-life cartridge: 3 months. In-use shelf-life inhaler: 1 year Recommended use: 6 cartridges per inhaler Note: The functioning of the RESPIMAT re-usable inhaler has been demonstrated in tests for 540 actuations (corresponding to 9 cartridges). Health Products Regulatory Authority 22 December 2021 CRN00CNCX Page 2 of 2 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not freeze. 6.5 NATURE AND CONTENTS OF CONTAINER Outer carton containing re-usable Respimat inhaler and cartridge. 1 re-useable Respimat inhaler and 1 cartridge, providing 60 puffs (30 medicinal doses). 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING Any unused product or waste material should be disposed of in accordance with local requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER IMED Healthcare Ltd. Unit 625 Kilshane Avenue Northwest Business קרא את המסמך השלם